BSE · SUDARSHAN
SUDARSHAN PHARMA INDUSTRIES LIMITED
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,579
of 5,004 stocks
▼ 91W
Peak #1,570 · 21 Sep 2026
SUDARSHAN PHARMA INDUSTRIES LIMITED is a smallcap company in the Chemicals space and is growing revenue rapidly, commands a premium earnings multiple, and earns a healthy return on equity.
Market Cap
931.23 Cr
P/E Ratio
38.45
P/B Ratio
5.74
ROE
14.95%
ROCE
30.30%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 174.42 Cr | 220.92 Cr | 168.01 Cr | 168.87 Cr |
| Net Profit | 5.61 Cr | 11.39 Cr | 4.15 Cr | 3.87 Cr |
| EPS | 0.23 | 0.48 | 0.18 | 0.16 |
| Operating Profit | 15.71 Cr | 23.23 Cr | 11.48 Cr | 10.17 Cr |
Shareholding pattern
Promoter
58.93%
Public
41.07%
PUBLIC BREAKDOWN
FII
19.87%
Individuals
17.83%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.